PDCD1 and neoplasm: PD-1 recognizes its ligand PD-L1, which is often expressed on tumor cells, and PD-L2, which is present on dendritic cells and macrophages, allowing these cells to employ interactions with inhibitory PD-1 to dampen T cell responses [81].